MAPT and amyotrophic lateral sclerosis: Remarkably, recent evidence now implicates phosphorylated tau in the pathology of amyotrophic lateral sclerosis (ALS), although distinct tissue-specific mechanisms (Abu-Rumeileh et al., 2025).